Latest Leadership Transition News

Genetic Signatures announces the upcoming departure of CEO Allison Rossiter, initiating a leadership transition as the company intensifies its focus on US market expansion.

Cannindah Resources has appointed Cameron Switzer as Managing Director and CEO, signaling a strategic push in its Mt Cannindah Copper-Gold Project. The company also sees a leadership reshuffle with the resignation of Chair Michael Hansel and appointment of Tony Rovira as Chair.

Pinnacle Minerals announces a strategic leadership reshuffle, appointing William Witham as Managing Director and CEO, Stephen Ross as Non-Executive Chairman, and welcoming Jay Stephenson to the board.

Boom Logistics has appointed Lester Fernandez as its permanent Managing Director and CEO, entrusting him to lead the company through its next phase of growth with a strong focus on safety and operational excellence.

Atomic Eagle Limited announces Phil Hoskins as new CEO following Daniel Major's unexpected non-start, spotlighting the Muntanga Uranium Project's substantial resource base.

Janus Electric Holdings announces the resignation of CEO Ian Campbell, with interim leadership appointed as the company searches for a successor.

Lynch Group Holdings has officially been acquired by Darwin Aus Bidco through a scheme of arrangement, with shareholders paid A$2.155 per share and the company set for imminent ASX delisting.

PWR Holdings has appointed Sharyn Williams as its new CEO and Managing Director, marking a strategic leadership transition while the search for a new CFO is underway.

Arcadia Minerals announces key leadership departures and a strategic pivot towards gold and critical minerals acquisitions, alongside planned drilling at its promising TVC Project in Namibia.

Whitebark Energy has appointed Nik Sykiotis as CEO, positioning the company to advance its strategic focus on natural hydrogen, helium, and hydrocarbons. Sykiotis’s operational expertise is expected to steer Whitebark through its next growth phase.

Talius Group appoints seasoned executive Pat Howard as CEO, with founder Graham Russell shifting to a strategic growth role, signalling a new phase of expansion and innovation.

Pacific Edge appoints Simon Flood as chairman designate, aiming to leverage his global investment expertise to navigate Medicare reimbursement challenges for its bladder cancer diagnostic tests in the US.